SCN9A and prostate cancer: Peptide toxins such as JZTX-I, which activate Nav1.7, can upregulate the expression of cytoskeleton-related proteins and activate the Rho GTPases-RhoA/Rac1 signaling pathway in prostate cancer cells [24].